BB BIOTECH AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.45 CHF | -0.25% |
|
-2.29% | -5.38% |
| Apr. 26 | Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps | MT |
| Apr. 25 | BB Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on BB Biotech AG
Price target over the last 5 years
History of analyst recommendation changes
670f7a865fb8d71f2443a2ae0c514cd.vjEDYNdxQpGwB9XRtJsMFlZoERPXiZJcB46NvRyuHTk.0UNyV-9Jb6WJTp29-PRHTmE-UieN1qQ2dbbbhC7HVHD0enYo5T574oVBmA~40c38e9b02e6fc4fdb4220dcd392cf3d
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
40.45
CHF
Average target price
47.7
CHF
Spread / Average Target
+17.92%
High Price Target
47.7
CHF
Spread / Highest target
+17.92%
Low Price Target
47.7
CHF
Spread / Lowest Target
+17.92%
Consensus detail
Consensus revision (last 18 months)
Analysts covering BB Biotech AG
| BAADER BANK | |
| INDEPENDENT RESEARCH | Tobias Gottschalt |
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- BION Stock
- Consensus BB Biotech AG
